Hua‐Jun Chen

Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang et al. · Clinical Cancer Research · 2016 · 992 citations

Medicine, Immunology, Oncology +17

Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Qing Zhou, Xu‐Chao Zhang, Zhihong Chen et al. · Journal of Clinical Oncology · 2011 · 247 citations

Medicine, Oncology, Pharmacology +17

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Chan-Yuan Zhang, Kai‐Cheng Peng, Ze-Xin Chen et al. · Cell Reports Medicine · 2023 · 177 citations · Full text

Medicine, Oncology, Chemotherapy +15

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

Feiyu Niu, Qing Zhou, Jin‐Ji Yang et al. · BMC Cancer · 2016 · 165 citations · Full text

Medicine, Oncology, Pathology +13

Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer

Jin‐Ji Yang, Hua‐Jun Chen, Hong‐Hong Yan et al. · Lung Cancer · 2012 · 164 citations

Medicine, Oncology, Pharmacology +17